Pretreatment Plasma IL-6 and YKL-40 and Overall Survival after Surgery for Metastatic Bone Disease of the Extremities.

Michala Skovlund SørensenThomas Colding-RasmussenPeter Frederik HorstmannKlaus HindsøChristian DehlendorffJulia Sidenius JohansenMichael Mørk Petersen

Published in: Cancers (2021)

High preoperative plasma IL-6 is an independent biomarker of short OS in patients undergoing surgery for MBD.

Keyphrases

patients undergoing
minimally invasive
soft tissue
small cell lung cancer
coronary artery bypass
bone mineral density
bone loss